医学
中低收入国家
髓系白血病
基础(证据)
发展中国家
环境卫生
家庭医学
经济增长
免疫学
考古
经济
历史
作者
Nirmalya Roy Moulik,Arlene Harriss-Buchan,Giuseppe Saglio,Meinolf Suttorp
标识
DOI:10.1080/08880018.2023.2301404
摘要
Despite being a rare disease, high-income countries (HICs) have formulated guidelines for management of pediatric CML (pCML). We conducted a survey amongst 24 physicians from 22 Low-Middle Income Countries (LMICs) to gather information regarding their practice and experience in treating children with pCML. Rarity of pCML, lack of adequate expertise, and setting-adapted guidelines along with limitations in diagnostic infrastructure as well as challenges in accessing tyrosine kinase inhibitors (TKIs) were identified as major barriers in optimum management of patients. For the first time in literature, our findings provide valuable insights into the multifaceted challenges faced in managing pCML in LMICs.
科研通智能强力驱动
Strongly Powered by AbleSci AI